Search
for

    Sort by

    Research 91–120 of 1000+

    1. Finasteride Elsevier eBooks · 2015
    2. In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss Journal of Ethnopharmacology · 2015 · 30 citations
    3. Carbamazepine-Induced Hair Loss Dicp-The annals of pharmacotherapy · 1985 · 12 citations
    4. Hypersensitivity Diseases Elsevier eBooks · 2014
    5. Drug eruptions A to Z 2005
    6. SDRIFE Induced by Tofacitinib Indian Journal of Dermatology · 2024 · 3 citations
    7. An urticarial drug eruption caused by tofacitinib for alopecia universalis Dermatologic Therapy · 2019 · 2 citations
    8. Drug Eruptions 2014
    9. Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations EClinicalMedicine · 2023 · 15 citations
    10. Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment International Journal of Advanced Multidisciplinary Research and Studies · 2024 · 1 citations
    11. Fluoxetine- and Sertraline-Related Hair Loss in a Teenager: A Case Report Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology · 2013 · 5 citations
    12. Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging International Journal of Pharmaceutics · 2023
    13. Cutaneous Adverse Events in Patients with Chronic Hepatitis C during Treatment with Directly Acting Antiviral Agents: A cohort study The Egyptian Journal of Hospital Medicine · 2024
    14. Reversible Anagen Effluvium Induced by Azathioprine: A Rare Adverse Effect Case Report International Journal of Science and Research (IJSR) · 2025
    15. Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration Cutaneous and ocular toxicology · 2020 · 4 citations
    16. Amiodarone-Induced Toxic Epidermal Necrolysis; Nilotinib-Associated Cerebrovascular Disease and Stroke; Pisa Syndrome Caused by Paliperidone; Macroglossia Associated with Methylprednisolone; Aromatase Inhibitor-Induced “Male Pattern Baldness” in Women? Acute Liver Failure Due to Etodolac Hospital Pharmacy · 2013
    17. Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs 2012 · 29 citations
    18. Non-hemorrhage-related adverse effects of rivaroxaban Archives of Medical Sciences · 2017 · 13 citations
    19. WARFARIN 2010
    20. Topical imiquimod—Be aware of the unexpected Journal of The American Academy of Dermatology · 2016 · 3 citations
    21. Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management Dermatology and Therapy · 2023
    22. Anaphylactic Shock Due to Intravenous Amiodarone; Delusional Parasitosis Associated with Donepezil; Connubial Androgenetic Alopecia; Ciprofloxacin-Induced Torsade de Pointes; Postvaccination Miller Fisher Syndrome; Life-Threatening Anaphylactoid Shock Caused by Recombinant Tissue Plasminogen Activator; Thiazide-Induced Hyponatremia Hospital Pharmacy · 2012
    23. Diseases of the skin. Drug ill effects on the skin. The BMJ · 1974 · 4 citations
    24. QUINAPRIL 2004
    25. SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION Rheumatology · 1993 · 7 citations
    26. A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital International journal of basic and clinical pharmacology · 2018
    27. PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE 2021
    28. Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy RSC Advances · 2025
    29. 267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome Journal of Investigative Dermatology · 2024
    30. Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression Cns & Neurological Disorders-drug Targets · 2020 · 2 citations